Literature DB >> 23462431

Management of immune cytopenias in patients with systemic lupus erythematosus - Old and new.

Kam Newman1, Mohammad Bagher Owlia, Ihab El-Hemaidi, Mojtaba Akhtari.   

Abstract

There are various immune cytopenias associated with systemic lupus erythematosus (SLE). The most common one is anemia; however, there are different etiologies for the anemia caused by SLE. Anemia could be due to chronic disease, secondary to renal insufficiency, blood loss, drug induced or autoimmune hemolysis. There are other very rare causes of anemia secondary to SLE which include red cell aplasia, aplastic anemia, and microangiopathic hemolytic anemia. Treatment of the anemia would be according to the cause. Leukopenia, neutropenia, and lymphopenia are hematologic complications associated with SLE, and in majority of cases no treatment is required. Thrombocytopenia is one of the complications of SLE and is usually treated by steroids. However, there are significant numbers of patients which will either not respond to or relapse after treatment. This article summarizes immune cytopenias seen in patients with SLE, and it also discusses management of these cytopenias.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23462431     DOI: 10.1016/j.autrev.2013.02.001

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  15 in total

1.  Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia in a patient with systemic lupus erythematosus and lupus nephritis.

Authors:  Lütfi Akyol; Soner Önem; Metin Özgen; Mehmet Sayarlıoğlu
Journal:  Eur J Rheumatol       Date:  2015-06-24

2.  Therapeutic Potential for Targeting the Suppressor of Cytokine Signalling-1 Pathway for the Treatment of SLE.

Authors:  B Sukka-Ganesh; J Larkin
Journal:  Scand J Immunol       Date:  2016-11       Impact factor: 3.487

Review 3.  Autoimmunity in 2013.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

Review 4.  Reviewing the recommendations for lupus in children.

Authors:  Zehra Serap Arıcı; Ezgi Deniz Batu; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

5.  IL10 restrains autoreactive B cells in transgenic mice expressing inactive RAG1.

Authors:  Victoria L Palmer; Alexandra N Worth; Robyn L Scott; Greg A Perry; Mei Yan; Quan-Zhen Li; Patrick C Swanson
Journal:  Cell Immunol       Date:  2018-06-13       Impact factor: 4.868

6.  Classical complement activation on human erythrocytes in subjects with systemic lupus erythematosus and a history of autoimmune hemolytic anemia.

Authors:  Pamela Hair; Daniel W Goldman; Jessica Li; Michelle Petri; Neel Krishna; Kenji Cunnion
Journal:  Lupus       Date:  2020-07-12       Impact factor: 2.911

7.  Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  J Am Heart Assoc       Date:  2017-02-27       Impact factor: 5.501

8.  NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus.

Authors:  Di Yang; Zhiqiang Tian; Mengjie Zhang; Weibing Yang; Jun Tang; Yuzhang Wu; Bing Ni
Journal:  Sci Rep       Date:  2017-04-28       Impact factor: 4.379

Review 9.  Immunotherapy treatments of warm autoimmune hemolytic anemia.

Authors:  Bainan Liu; Wangang Gu
Journal:  Clin Dev Immunol       Date:  2013-09-11

10.  Heparin-Related Thrombocytopenia Triggered by Severe Status of Systemic Lupus Erythematosus and Bacterial Infection.

Authors:  Satoshi Suzuki; Shihoko Nakajima; Taiki Ando; Keisuke Oda; Manabu Sugita; Kunimi Maeda; Yutaka Nakiri; Yoshinari Takasaki
Journal:  Case Rep Rheumatol       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.